J. M. Arrang, M. Garbarg, J. C. Lancelot, J. M. Lecomte, H. Pollard et al., Highly potent and selective ligands for histamine H3-receptors, Nature, vol.327, issue.6118, 1987.
DOI : 10.1038/327117a0

C. R. Baumann and C. L. Bassetti, Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter, Sleep Medicine Reviews, vol.9, issue.4, pp.253-268, 2005.
DOI : 10.1016/j.smrv.2005.01.005

L. Bayer, E. Eggermann, M. Serafin, B. Saint-mleux, D. Machard et al., Orexins (hypocretins) directly excite tuberomammillary neurons, European Journal of Neuroscience, vol.901, issue.9, pp.1571-1575, 2001.
DOI : 10.1046/j.0953-816x.2001.01777.x

M. Billiard, C. Bassetti, Y. Dauvilliers, L. Dolenc-groselj, G. J. Lammers et al., EFNS guidelines on management of narcolepsy, European Journal of Neurology, vol.13, issue.1, pp.1035-1048, 2006.
DOI : 10.1002/ana.20339

J. Black and W. C. Houghton, Sodium oxybate improves excessive daytime sleepiness in narcolepsy, Sleep, vol.29, pp.939-946, 2006.

P. Bonaventure, M. Letavic, C. Dugovic, S. Wilson, L. Aluisio et al., Histamine H3 receptor antagonists: From target identification to drug leads, Biochemical Pharmacology, vol.73, issue.8, pp.1084-1096, 2007.
DOI : 10.1016/j.bcp.2006.10.031

P. Bourgin, S. Huitron-resendiz, A. D. Spier, V. Fabre, B. Morte et al., Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons, J Neurosci, vol.20, pp.7760-7765, 2000.

M. L. Bouthenet, M. Ruat, N. Sales, M. Garbarg, and J. C. Schwartz, A detailed mapping of histamine H1-receptors in guinea-pig central nervous system established by autoradiography with [125I]iodobolpyramine. Neurosci, pp.553-600, 1988.

R. E. Brown, O. A. Sergeeva, K. S. Eriksson, and H. L. Haas, Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline), J Neurosci, vol.22, pp.8850-8859, 2002.

R. M. Chemelli, J. T. Willie, C. M. Sinton, J. K. Elmquist, T. Scammell et al., Narcolepsy in orexin Knockout Mice, Cell, vol.98, issue.4, pp.437-451, 1999.
DOI : 10.1016/S0092-8674(00)81973-X

Y. Dauvilliers, I. Arnulf, and E. Mignot, Narcolepsy with cataplexy, The Lancet, vol.369, issue.9560, pp.499-511, 2007.
DOI : 10.1016/S0140-6736(07)60237-2

URL : https://hal.archives-ouvertes.fr/hal-00534816

K. S. Eriksson, O. Sergeeva, R. E. Brown, and H. L. Haas, Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus, J Neurosci, vol.21, pp.9273-9279, 2001.

L. Ferraro, S. Tanganelli, W. T. O-'connor, T. Antonelli, F. Rambert et al., The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor, Neuroscience Letters, vol.220, issue.1, pp.5-8, 1996.
DOI : 10.1016/S0304-3940(96)13212-2

N. Fujiki, T. Cheng, F. Yoshino, and S. Nishino, Specificity of direct transition from wake to REM sleep in orexin/ataxin-3 transgenic narcoleptic mice, Experimental Neurology, vol.217, issue.1, p.29, 2006.
DOI : 10.1016/j.expneurol.2009.01.015

Z. L. Huang, W. M. Qu, W. D. Li, T. Mochizuki, N. Eguchi et al., Arousal effect of orexin A depends on activation of the histaminergic system, Proceedings of the National Academy of Sciences, vol.98, issue.17, pp.9965-9970, 2001.
DOI : 10.1073/pnas.181330998

M. W. Johns, A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale, Sleep, vol.14, issue.6, pp.540-545, 1991.
DOI : 10.1093/sleep/14.6.540

S. J. Kish, M. Mamelak, C. Slimovitch, L. M. Dixon, A. Lewis et al., Brain neurotransmitter changes in human narcolepsy, Neurology, vol.42, issue.1, pp.229-334, 1992.
DOI : 10.1212/WNL.42.1.229

T. M. Korotkova, O. A. Sergeeva, A. A. Ponomarenko, and H. L. Haas, Histamine excites noradrenergic neurons in locus coeruleus in rats, Neuropharmacology, vol.49, issue.1, pp.129-134, 2005.
DOI : 10.1016/j.neuropharm.2005.03.001

X. Ligneau, L. Landais, D. Perrin, J. Piriou, M. Uguen et al., Brain histamine and schizophrenia: Potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649, Biochemical Pharmacology, vol.73, issue.8, 2007.
DOI : 10.1016/j.bcp.2007.01.023

URL : https://hal.archives-ouvertes.fr/inserm-00150117

X. Ligneau, J. S. Lin, G. Vanni-mercier, M. Jouvet, J. L. Muir et al., Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist, J Pharmacol Exp Ther, vol.287, pp.658-666, 1998.

X. Ligneau, D. Perrin, L. Landais, J. C. Camelin, T. P. Calmels et al., BF2.649 [1-??piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology, Journal of Pharmacology and Experimental Therapeutics, vol.320, issue.1, pp.365-375, 2007.
DOI : 10.1124/jpet.106.111039

URL : https://hal.archives-ouvertes.fr/inserm-00150117

J. S. Lin, B. Roussel, H. Akaoka, P. Fort, G. Debilly et al., Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat, Brain Research, vol.591, issue.2, pp.319-326, 1992.
DOI : 10.1016/0006-8993(92)91713-O

J. S. Lin, PHYSIOLOGICAL REVIEW ARTICLE: Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons, Sleep Medicine Reviews, vol.4, issue.5, pp.471-503, 2000.
DOI : 10.1053/smrv.2000.0116

L. Lin, J. Faraco, R. Li, H. Kadotani, W. Rogers et al., The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene, Cell, vol.98, issue.3, pp.365-376, 1999.
DOI : 10.1016/S0092-8674(00)81965-0

E. Mignot, Narcolepsy: Pharmacology, Pathophysiology, and Genetics, Principles and Practice of Sleep Medicine, pp.761-779, 2005.
DOI : 10.1016/B0-72-160797-7/50071-9

E. Mignot and S. Nishino, Emerging therapies in narcolepsy-cataplexy, Sleep, vol.28, pp.754-763, 2005.

T. Mochizuki, A. Crocker, S. Mccormack, M. Yanagisawa, T. Sakurai et al., Behavioral State Instability in Orexin Knock-Out Mice, Journal of Neuroscience, vol.24, issue.28, pp.6291-6300, 2004.
DOI : 10.1523/JNEUROSCI.0586-04.2004

S. Morisset, A. Rouleau, X. Ligneau, F. Gbahou, J. Tardivel-lacombe et al., High constitutive activity of native H3 receptors regulates histamine neurons in brain, Nature, vol.408, pp.860-864, 2000.

S. Nishino, N. Fujiki, B. Ripley, E. Sakurai, M. Kato et al., Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs, Neuroscience Letters, vol.313, issue.3, pp.125-128, 2001.
DOI : 10.1016/S0304-3940(01)02270-4

S. Nishino, B. Ripley, S. Overeem, G. J. Lammers, and E. Mignot, Hypocretin (orexin) deficiency in human narcolepsy, The Lancet, vol.355, issue.9197, pp.39-40, 2000.
DOI : 10.1016/S0140-6736(99)05582-8

R. Parmentier, C. Anaclet, C. Guhennec, E. Brousseau, D. Bricout et al., The brain H3-receptor as a novel therapeutic target for vigilance and sleep???wake disorders, Biochemical Pharmacology, vol.73, issue.8, pp.1157-1171, 2007.
DOI : 10.1016/j.bcp.2007.01.002

URL : https://hal.archives-ouvertes.fr/inserm-00150083

R. Parmentier, H. Ohtsu, Z. Djebbara-hannas, J. L. Valatx, T. Watanabe et al., Anatomical, physiological and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioural and sleep-wake control, J Neurosci, vol.22, pp.7695-7711, 2002.

C. Pillot, A. Heron, V. Cochois, J. Tardivel-lacombe, X. Ligneau et al., A detailed mapping of the histamine H3 receptor and its gene transcripts in rat brain, Neuroscience, vol.114, issue.1, pp.173-193, 2002.
DOI : 10.1016/S0306-4522(02)00135-5

T. E. Scammell, I. V. Estabrooke, M. T. Mccarthy, R. M. Chemelli, M. Yanagisawa et al., Hypothalamic arousal regions are activated during modafinil-induced wakefulness, J Neurosci, vol.20, pp.8620-8628, 2000.

E. Schlicker, A. Behling, G. Lummen, and M. Gothert, Histamine H3-receptor-mediated inhibition of noradrenaline release in the mouse brain cortex, Naunyn Schmiedebergs Arch Pharmacol, vol.345, pp.489-493, 1992.

J. C. Schwartz, J. M. Arrang, M. Garbarg, H. Pollard, and M. Ruat, Histaminergic transmission in the mammalian brain, Physiol Rev, vol.71, pp.1-51, 1991.

J. E. Sherin, J. K. Elmquist, F. Torrealba, and C. B. Saper, Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat, J Neurosci, vol.18, pp.4705-4721, 1998.

J. M. Siegel, Narcolepsy, Cell, vol.98, issue.4, pp.409-412, 1999.
DOI : 10.1016/S0092-8674(00)81969-8

J. G. Sutcliffe and L. De-lecea, THE HYPOCRETINS: SETTING THE AROUSAL THRESHOLD, Nature Reviews Neuroscience, vol.355, issue.5, pp.339-349, 2002.
DOI : 10.1016/S0896-6273(01)00293-8

K. Takahashi, J. S. Lin, and K. Sakai, Neuronal Activity of Histaminergic Tuberomammillary Neurons During Wake-Sleep States in the Mouse, Journal of Neuroscience, vol.26, issue.40, pp.10292-10298, 2006.
DOI : 10.1523/JNEUROSCI.2341-06.2006

URL : https://hal.archives-ouvertes.fr/inserm-00408027

S. Tanganelli, M. P. Mora, L. Ferraro, J. Mendez-franco, L. Beani et al., Modafinil and cortical ??-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins, European Journal of Pharmacology, vol.273, issue.1-2, pp.63-71, 1995.
DOI : 10.1016/0014-2999(94)00675-W

J. L. Valatx and R. Bugat, Facteurs g??n??tiques dans le d??terminisme du cycle veille-sommeil chez la souris, Brain Research, vol.69, issue.2, pp.315-330, 1974.
DOI : 10.1016/0006-8993(74)90009-2

J. L. Valatx, Enregistrement chronique des activités électriques cérébrales, musculaires et oculaires chez la souris, CR Séances Soc Bio. Fil, vol.165, pp.112-115, 1971.

G. Vanni-mercier, S. Gigout, G. Debilly, and J. S. Lin, Waking selective neurons in the posterior hypothalamus and their response to histamine H3-receptor ligands: an electrophysiological study in freely moving cats, Behavioural Brain Research, vol.144, issue.1-2, pp.227-241, 2003.
DOI : 10.1016/S0166-4328(03)00091-3

URL : https://hal.archives-ouvertes.fr/inserm-00408041

J. P. Wisor and K. S. Eriksson, Dopaminergic???adrenergic interactions in the wake promoting mechanism of modafinil, Neuroscience, vol.132, issue.4, pp.1027-1034, 2005.
DOI : 10.1016/j.neuroscience.2005.02.003

M. F. Wu, S. A. Gulyani, E. Yau, E. Mignot, B. Phan et al., Locus coeruleus neurons: cessation of activity during cataplexy, Neuroscience, vol.91, issue.4, pp.1389-1399, 1999.
DOI : 10.1016/S0306-4522(98)00600-9